Danaherrp (id:8488 DHR)
235.09 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/21/2024 6:34:20 PM)
Exchange closed, opens in 14 hours 55 minutes
About Danaherrp
Market Capitalization 174.45B
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.
| Headquarters (address) |
2200 Pennsylvania Avenue, North West Washington 20037-1701 DC United States |
| Phone | 202 828 0850 |
| Website | https://www.danaher.com |
| Employees | 61,000 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Ticker | DHR |
| Exchange | New York Stock Exchange |
| Currency | USD |
| 52 week range | 215.68 - 281.70 |
| Market Capitalization | 174.45B |
| Dividend yield forward | 0.463 % |
| Dividend yield forward United States (ID:6, base:1863) | 4.21 % |
| P/E trailing | 45.57 |
| P/E forward | 28.82 |
| Price/Sale | 7.35 |
| Price/Book | 3.40 |
| Beta | 0.881 |
| EPS | 5.30 |
| EPS United States (ID:6, base:3394) | 24.31 |
Dividend growth streak
Danaherrp has raised their dividend 6.00 years in a row. This is above the 4.478497 year average in the 'Diagnostics & Research' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Danaherrp has raised their dividend 0.463 years in a row. This is below the 41124.611000 year average in the 'Diagnostics & Research' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Danaherrp has raised their dividend 243.71 years in a row. This is above the 24.014500 year average in the 'Diagnostics & Research' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Danaherrp has raised their dividend 114.76 years in a row. This is above the 12.586200 year average in the 'Diagnostics & Research' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Danaherrp has raised their dividend 76.44 years in a row. This is above the 10.156100 year average in the 'Diagnostics & Research' industry
Payout Ratio
Payout Ratio: Danaherrp has raised their dividend 24.91 years in a row. This is below the 146.971700 year average in the 'Diagnostics & Research' industry
Dividend growth streak
Danaherrp has raised their dividend 6.00 years in a row. This is above the 4.478497 year average in the 'Diagnostics & Research' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Danaherrp has raised their dividend 0.463 years in a row. This is below the 41124.611000 year average in the 'Diagnostics & Research' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Danaherrp has raised their dividend 243.71 years in a row. This is above the 24.014500 year average in the 'Diagnostics & Research' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Danaherrp has raised their dividend 114.76 years in a row. This is above the 12.586200 year average in the 'Diagnostics & Research' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Danaherrp has raised their dividend 76.44 years in a row. This is above the 10.156100 year average in the 'Diagnostics & Research' industry
Payout Ratio
Payout Ratio: Danaherrp has raised their dividend 24.91 years in a row. This is below the 146.971700 year average in the 'Diagnostics & Research' industry